Boehringer Ingelheim InPedILD Phase III trial showed encouraging results for both primary endpoints
New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease
New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease
The Bulk Drug Parks to be developed under the scheme will provide common infrastructure facilities at one place thereby creating a robust ecosystem for the bulk drug manufacturing in the country and also reducing manufacturing cost significantly
Lutio has the potential to offer significant cost savings when available to UK patients.
The cash consideration for the above acquisition will be Euro 26 million.
The summit to demonstrate revolutionary techniques and advanced medical procedures for treating CTO
~96% decline reported in Malaria cases in Madhya Pradesh, due to public-private-people partnership
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
The Elecsys Amyloid Plasma Panel has the potential to ensure better identification of patients that require further confirmatory testing, supporting a more timely and accessible diagnosis.
The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements
Subscribe To Our Newsletter & Stay Updated